A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Endocrine Fellowship Program Bookmark and Share

Endocrine Fellowship Program with Harbor-UCLA Medical Center

Background
The Endocrine Fellowship Program with Harbor-UCLA was expanded to include an additional site at City of Hope’s Department of Diabetes, Endocrinology & Metabolism, which offers advanced clinical programs in diabetes, thyroid cancer, neuroendocrine tumors, osteoporosis, calcium and electrolyte disturbances, and sexual and reproductive disorders. The department also offers several clinical and basic science research programs such as molecular signaling, hormonal factors and hormone discovery, cellular mechanisms of atherosclerosis, development of advanced glycation end-products (AGE) inhibitors and AGE breakers, as well as diabetic immunology and islet isolation, proliferation and transplantation. Additionally, joint studies with the departments of Hematology & Hematopoietic Cell Transplantation and Medical Oncology are being conducted to evaluate endocrine-related complications of cancer and cancer treatment.
 
Diabetes Training
Fellowship training at City of Hope focuses on treatment options for patients with diabetes, including patients with type 1, type 2 and those with drug and disease-induced forms of diabetes, such as that seen in cancer patients on steroid therapy and IV nutritional support. Fellows gain experience with advanced monitoring and treatment strategies for diabetes, including continuous glucose monitoring, oral medications and insulin pump therapy. At City of Hope, fellows also participate in the ongoing clinical islet transplantation program and are involved in the screening and follow-up care of islet transplant recipients with and without prior renal transplants. Training highlights also include experience with the diagnosis and management of diabetes-related complications and diabetes-associated disorders such as acute metabolic deteriorations, retinopathy, neuropathy, hyperlipidemia, hypertension, coronary disease, peripheral vascular disease and sexual dysfunction. Fellows also receive training on the implementation of non-drug strategies for the management of diabetes and its complications, including weight reduction and behavioral modification.
 
Other Endocrine Disorders
At City of Hope, fellows receive in-depth training in other endocrine disciplines, including: thyroid disorders and thyroid cancers, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer and its treatments, and osteoporosis and other metabolic bone diseases.
 
Program Benefits
The training at Harbor-UCLA is useful to City of Hope endocrine fellows as it provides an introduction in the care of underserved populations. Fellows gain experience with management of disease manifestations and disorders that are not frequently encountered in the populations seeking care at City of Hope (e.g., severe neuropathy requiring leg amputation and vision-threatening retinopathy) as well as gestational diabetes. Another benefit from City of Hope’s association with Harbor-UCLA is the continuing interactions with the faculty and trainees of each highly-rated program. Physicians participating in the joint fellowship program at City of Hope and Harbor-UCLA have the opportunity to receive training in islet transplantation that prepares them to meet the requirements set by the United Network of Organ Sharing, a national organ procurement agency, for establishing new islet transplantation centers.
 
Curriculum
City of Hope endocrinology fellows are primarily allocated to the City of Hope site, where they receive the majority of their training. A segment of their education is also completed at the Harbor-UCLA program site. Similarly, endocrine fellows at Harbor-UCLA have the opportunity to receive a portion of their training at City of Hope. This type of curriculum exposes fellows to a wide range of endocrine disciplines including: type 1 and type 2 diabetes, gestational diabetes, diabetes-related complications, diabetes-associated disorders, clinical islet transplantation, thyroid disorders and thyroid cancer, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer, osteoporosis and sexual dysfunction. Upon completion of the program, endocrine fellows are fully trained in the treatment and management of endocrinology-related diseases and disorders.
 
Training Requirements
Physicians with an M.D. degree at any stage of their postdoctoral training will be considered for the program. Preference is given to those who have completed residency in internal medicine, pediatrics, ob/gyn, urology or other related specialties. The program is also well suited for postdoctoral training for candidates with Ph.D. degrees. All candidates who have completed at least three years of residency in the United States must possess a California license to practice and do clinical training.
 
Program History
City of Hope was established in 1913 as a charitable hospital supported by a philanthropic volunteer organization. Today, the organization is dedicated to the prevention and cure of life-threatening diseases, such as cancer and diabetes, through both innovative research and compassionate patient care. City of Hope’s diabetes program was established in 1971 by Rachmiel Levine, M.D., and is currently led by Fouad R. Kandeel, M.D., Ph.D., in the Leslie & Susan Gonda (Goldschmied) Diabetes & Genetic Research Center, a state-of-the-art research building.
 

Endocrine Fellowship Program

Endocrine Fellowship Program with Harbor-UCLA Medical Center

Background
The Endocrine Fellowship Program with Harbor-UCLA was expanded to include an additional site at City of Hope’s Department of Diabetes, Endocrinology & Metabolism, which offers advanced clinical programs in diabetes, thyroid cancer, neuroendocrine tumors, osteoporosis, calcium and electrolyte disturbances, and sexual and reproductive disorders. The department also offers several clinical and basic science research programs such as molecular signaling, hormonal factors and hormone discovery, cellular mechanisms of atherosclerosis, development of advanced glycation end-products (AGE) inhibitors and AGE breakers, as well as diabetic immunology and islet isolation, proliferation and transplantation. Additionally, joint studies with the departments of Hematology & Hematopoietic Cell Transplantation and Medical Oncology are being conducted to evaluate endocrine-related complications of cancer and cancer treatment.
 
Diabetes Training
Fellowship training at City of Hope focuses on treatment options for patients with diabetes, including patients with type 1, type 2 and those with drug and disease-induced forms of diabetes, such as that seen in cancer patients on steroid therapy and IV nutritional support. Fellows gain experience with advanced monitoring and treatment strategies for diabetes, including continuous glucose monitoring, oral medications and insulin pump therapy. At City of Hope, fellows also participate in the ongoing clinical islet transplantation program and are involved in the screening and follow-up care of islet transplant recipients with and without prior renal transplants. Training highlights also include experience with the diagnosis and management of diabetes-related complications and diabetes-associated disorders such as acute metabolic deteriorations, retinopathy, neuropathy, hyperlipidemia, hypertension, coronary disease, peripheral vascular disease and sexual dysfunction. Fellows also receive training on the implementation of non-drug strategies for the management of diabetes and its complications, including weight reduction and behavioral modification.
 
Other Endocrine Disorders
At City of Hope, fellows receive in-depth training in other endocrine disciplines, including: thyroid disorders and thyroid cancers, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer and its treatments, and osteoporosis and other metabolic bone diseases.
 
Program Benefits
The training at Harbor-UCLA is useful to City of Hope endocrine fellows as it provides an introduction in the care of underserved populations. Fellows gain experience with management of disease manifestations and disorders that are not frequently encountered in the populations seeking care at City of Hope (e.g., severe neuropathy requiring leg amputation and vision-threatening retinopathy) as well as gestational diabetes. Another benefit from City of Hope’s association with Harbor-UCLA is the continuing interactions with the faculty and trainees of each highly-rated program. Physicians participating in the joint fellowship program at City of Hope and Harbor-UCLA have the opportunity to receive training in islet transplantation that prepares them to meet the requirements set by the United Network of Organ Sharing, a national organ procurement agency, for establishing new islet transplantation centers.
 
Curriculum
City of Hope endocrinology fellows are primarily allocated to the City of Hope site, where they receive the majority of their training. A segment of their education is also completed at the Harbor-UCLA program site. Similarly, endocrine fellows at Harbor-UCLA have the opportunity to receive a portion of their training at City of Hope. This type of curriculum exposes fellows to a wide range of endocrine disciplines including: type 1 and type 2 diabetes, gestational diabetes, diabetes-related complications, diabetes-associated disorders, clinical islet transplantation, thyroid disorders and thyroid cancer, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer, osteoporosis and sexual dysfunction. Upon completion of the program, endocrine fellows are fully trained in the treatment and management of endocrinology-related diseases and disorders.
 
Training Requirements
Physicians with an M.D. degree at any stage of their postdoctoral training will be considered for the program. Preference is given to those who have completed residency in internal medicine, pediatrics, ob/gyn, urology or other related specialties. The program is also well suited for postdoctoral training for candidates with Ph.D. degrees. All candidates who have completed at least three years of residency in the United States must possess a California license to practice and do clinical training.
 
Program History
City of Hope was established in 1913 as a charitable hospital supported by a philanthropic volunteer organization. Today, the organization is dedicated to the prevention and cure of life-threatening diseases, such as cancer and diabetes, through both innovative research and compassionate patient care. City of Hope’s diabetes program was established in 1971 by Rachmiel Levine, M.D., and is currently led by Fouad R. Kandeel, M.D., Ph.D., in the Leslie & Susan Gonda (Goldschmied) Diabetes & Genetic Research Center, a state-of-the-art research building.
 
APPLICATION
All endocrinology Internal Medicine applicants are through ERAS. Please go to the ERAS web site at for the application process.
CONTACT
Ken C. Chiu, M.D., F.A.C.E.
Program Site Director
Endocrinology Fellowship
Department of Clinical Diabetes, Endocrinology & Metabolism
City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: (626) 256-4673
E-mail Address: kchiu@coh.org
 
A request for additional information may be made to the Fellowship Coordinator through e-mail at kramos@coh.org.
Ranked as one of  "America’s Best Hospitals" in cancer by U.S. News & World Report, City of Hope is a pioneer in the fields of hematopoietic cell transplantation and genetics. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, City of Hope's research and treatment protocols advance care throughout the nation.
 
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
City of Hope’s Clinical Investigation Training Program (CITP) provides scholars with clinical research fundamentals and the comprehensive skill set required for today's comprehensive clinical investigator.
Residency and Fellowship Programs
Residency and Fellowship Programs City of Hope offers exciting and challenging clinical fellowship opportunities to expand your knowledge and professional expertise. Current Training Activities


NEWS & UPDATES
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...
  • The promise of stem cell therapy has long been studied in laboratories. Now, as medicine enters an era in which this therapy will be increasingly available to patients, the nurses who help deliver it will be in the spotlight. City of Hope, which has launched its Alpha Clinic for Cell Therapy and Innovation (ACT...
  • Just because you can treat a condition, such as high cholesterol, at the end of life — well, that doesn’t mean you should. That’s the basic lesson of a study to be published March 30 in JAMA Internal Medicine. The ramifications go far beyond that. The research, in which City of Hope’s Betty Fe...
  • The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. However, the adage that a little knowledge is a dangerous thing is applicable: Without context for what a test result means, and without meaningful guidance...
  • Standard prostate biopsies haven’t changed significantly in the past 30 years – nor have the problems inherent with them. Regular biopsies have an expected error rate: Tumors may potentially be undersampled and, 30 percent of the time, men who undergo a radical prostatectomy are found to have more aggress...
  • In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cellular Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem-cell-based therapy. The Alpha Clini...
  • How does the environment affect our health? Specifically, how does it affect our risk of cancer? City of Hope physicians and researchers recently answered those questions in an Ask the Experts event in Corona, California, explaining the underlying facts about how the environment can affect our health. Moderator...
  • Nurses and other medical professionals have come to understand that it’s not enough just to fight disease. They also must provide pain relief, symptom control, and an unrelenting commitment to improve patients’ quality of life — especially at the end of life. Not too long ago, this was a relatively ...
  • “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer.” These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address. So what is precision medicine, and how close are we to making it a reality for...
  • March is Colon Cancer Awareness Month. How sad, yet how serendipitous, that the co-creator of “The Simpsons” Sam Simon passed away in March after a four-year battle against colon cancer. What message can we all learn from his illness that can help us prevent and overcome colon cancer in our own lives? Colon can...
  • Misagh Karimi, M.D., assistant clinical professor, is a medical oncologist at one of City of Hope’s newest community practice locations, located in Corona in Riverside County. A recent community health report from Corona’s public health department stated that obesity rates for teens and adults in Riverside Coun...
  • In 1975, the median survival for patients with ovarian cancer was about 12 months. Today, the median survival is more than 5 years. Although researchers and clinicians are far from satisfied, the progress in ovarian cancer treatment is encouraging, said Robert Morgan, M.D., F.A.C.P., professor of medical oncolo...
  • Colorectal cancer may be one of the most common cancers in both men and women, but it’s also one of the most curable cancers. Today, because of effective screening tests and more advanced treatment options, there are more than 1 million survivors of colorectal cancer in the United States. Here, colorectal...
  • Breast cancer treatment can damage a woman’s ability to become pregnant, making the impact on fertility one of the key factors that many consider when choosing a therapy regimen. Now a study has found that breast cancer patients treated with a hormone-blocking drug in addition to chemotherapy were less li...
  • My colleagues in the clinic know I’ve got a soft spot. Last week, a patient of mine offered me a fantastic compliment. “You’re looking younger these days, Dr. Pal!” she said, offering me a big hug as she proceeded out of the clinic room. Lovely, I thought. The early morning workouts are paying off. She continue...